298
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Development of novel cationic chitosan-and anionic alginate–coated poly(d,l-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

, , , , , & show all
Pages 5501-5516 | Published online: 17 Oct 2012

References

  • ManachCScalbertAMorandCRémésyCJiménezLPolyphenols: food sources and bioavailabilityAm J Clin Nutr200479572774715113710
  • ScalbertAManachCMorandCRémésyCJiménezLDietary polyphenols and the prevention of diseasesCrit Rev Food Sci Nutr200545428730616047496
  • ScalbertAJohnsonITSaltmarshMPolyphenols: antioxidants and beyondAm J Clin Nutr200581Suppl 1215S217S15640483
  • SurhYJCancer chemoprevention with dietary phytochemicalsNat Rev Cancer200331076878014570043
  • KhanNAfaqFMukhtarHCancer chemoprevention through dietary antioxidants: progress and promiseAntioxid Redox Signal200810347551018154485
  • YangCSLandauJMHuangMTNewmarkHLInhibition of carcinogenesis by dietary polyphenolic compoundsAnnu Rev Nutr20012138140611375442
  • FrémontLBiological effects of resveratrolLife Sci200066866367310680575
  • SunAYWangQSimonyiASunGYBotanical phenolics and neurodegenerationBenzieIFFWachtel-GalorSHerbal Medicine: Biomolecular and Clinical Aspects2nd edBoca RatonCRC Press2011
  • BaurJAPearsonKJPriceNLResveratrol improves health and survival of mice on a high-calorie dietNature2006444711733734217086191
  • CampagnaMRivasCAntiviral activity of resveratrolBiochem Soc Trans201038Pt 1505320074034
  • YanYGaoYYLiuBQNiuXFZhuangYWangHQResveratrol-induced cytotoxicity in human Burkitt’s lymphoma cells is coupled to the unfolded protein responseBMC Cancer20101044520723265
  • AggarwalBBBhardwajAAggarwalRSSeeramNPShishodiaSTakadaYRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2004245A2783284015517885
  • GoswamiSKDasDKResveratrol and chemopreventionCancer Lett200928411619261378
  • AhmadNAdhamiVMAfaqFFeyesDKMukhtarHResveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cellsClin Cancer Res2001751466147311350919
  • SignorelliPGhidoniRResveratrol as an anticancer nutrient: molecular basis, open questions and promisesJ Nutr Biochem200516844946616043028
  • LuZChengBHuYLZhangYHZouGLComplexation of resveratrol with cyclodextrins: solubility and antioxidant activityFood Chem200911311720
  • JuanMEBuenafuenteJCasalsIPlanasJMPlasmatic levels of trans-resveratrol in ratsFood Res Int2002352195199
  • MuninAEdwards-LévyFEncapsulation of natural polyphenolic compounds; a reviewPharmaceutics201134793829
  • AmriAChaumeilJCSfarSCharrueauCAdministration of resveratrol: what formulation solutions to bioavailability limitations?J Control Release2012158218219321978644
  • ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
  • ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
  • RanganathanRMadanmohanSKesavanANanomedicine: towards development of patient-friendly drug-delivery systems for oncological applicationsInt J Nanomedicine201271043106022403487
  • SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res20096951712171619223530
  • SannaVPintusGRoggioAMTargeted biocompatible nanoparticles for the delivery of (−)-epigallocatechin 3-gallate to prostate cancer cellsJ Med Chem20115451321133221306166
  • HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: role of tumor type and microenvironmentProc Natl Acad Sci U S A1998958460746129539785
  • SannaVSechiMNanoparticle therapeutics for prostate cancer treatmentMaturitas2012731273222341739
  • SannaVRoggioAMPosadinoAMNovel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide- co-caprolactone) for prostate cancer treatment: formulation, characterization and cytotoxicity studiesNanoscale Res Lett20116126021711774
  • SiddiquiIAMukhtarHNanochemoprevention by bioactive food components: a perspectivePharm Res20102761054106020221894
  • SiddiquiIAAdhamiVMChamcheuJCMukhtarHImpact of nanotecnology in cancer: emphasis on nanochemopreventionInt J Nanomedicine2012759160522346353
  • SannaVSechiMNanoparticle therapeutics for prostate cancer treatmentNanomedicine20128Suppl 1S31S3622640911
  • SiddiquiAIShuklaYMukhtarHNanoencapsulation of natural products for chemopreventionJ Nanomed Nanotechnol20112104e
  • ShaoJLiXLuXEnhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levelsColloids Surf B Biointerfaces2009721404719395246
  • TeskacKKristlJThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrolInt J Pharm20103901616919833178
  • CaddeoCTeskacKSinicoCKristlJEffect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cellsInt J Pharm20083631–218319118718515
  • ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
  • MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers2011331377139722577513
  • DavaranSRashidiMRPourabbasBDadashzadehMHaghshenasNMAdriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterizationInt J Nanomedicine20061453553917722284
  • LiSHCaiSXLiuBMaKWWangZPLiXKIn vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factorActa Pharmacol Sin200627675475916723096
  • GeorgeMAbrahamTEPolyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a reviewJ Control Release2006114111416828914
  • AgrawalPStrijkersGJNicolayKChitosan-based systems for molecular imagingAdv Drug Deliv Rev2010621425819861142
  • TakkaSGürelAEvaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterizationAAPS Pharm Sci Tech2010111460466
  • ZhouJRomeroGRojasEMaLMoyaSGaoCLayer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and folic acid binding to achieve selective cell targetingJ Colloid Interface Sci2010345224124720227712
  • WangQJamalSDetamoreMSBerklandCPLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cellsJ Biomed Mater Res A201196352052721254383
  • ChoiDHParkCHKimIHChunHJParkKHanDKFabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery systemJ Control Release2010147219320120647022
  • SunBRibesAMLeandroMCBelchiorAPSprangerMIStilbenes: quantitative extraction from grape skins, contribution of grape solids to wine and variation during wine maturationAnal Chim Acta20065631–2382390
  • ElgindyNElkhodairyKMolokhiaAElZoghbyABiopolymeric nanoparticles for oral protein delivery: design and in vitro evaluationJ Nanomed Nanotechnol201123110
  • López-HernándezJPaseiro-LosadaPSanches-SilvaATLage-YustyMAStudy of the changes of trans-resveratrol caused by ultraviolet light and determination of trans- and cis-resveratrol in Spanish white winesEur Food Res Technol2007225789796
  • Quintanar-GuerreroDAllemannEFessiHDoelkerEPreparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymersDrug Dev Ind Pharm19982412111311289876569
  • GuoCGemeinhartRAUnderstanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particlesEur J Pharm Biopharm200870259760418602994
  • MahmoodiMKhosroshahiMEAtyabiFLaser thrombolysis and in vitro study of tPA release encapsulated by chitosan coated PLGA nanoparticles for AMIInt J Biol Biomed Eng2010423542
  • MichlerGHBaltá CallejaFJPart III. Nano- and microcomposites: interphaseKarger-KocsisJFakirovSNano- and Micromechanics of Polymers Blends and CompositesCincinnatiHanser2009
  • SomasundaranPMehtaSCYuXKrishnakumarSCap 6: colloid systems and interfaces stability of dispersions through polymer and surfactant adsorptionBirdiKSHandbook of Surface and Colloid Chemistry3rd edBoca RatonCRC Press2008
  • SoppimathKSAminabhaviTMKulkarniARRudzinskiWEBiodegradable polymeric nanoparticles as drug delivery devicesJ Control Release2001701–212011166403
  • ZhengCHGaoJQZhangYPLiangWQA protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheresBiochem Biophys Res Commun200432341321132715451441
  • TrimailleTPichotCDelairTSurface functionalization of poly(D,L-lactic acid) nanoparticles with poly(ethylenimine) and plasmid DNA by the layer-by-layer approachColloids Surf A Physicochem Eng Asp200322113948
  • RiouVVernhetADocoTMoutounetMAggregation of grape seed tannins in model wine – effect of wine polysaccharidesFood Hydrocoll20021611723
  • HandiqueJGBaruahJBPolyphenolic compounds: an overviewReact Funct Polym200252163188
  • SankaliaMGMashruRCSankaliaJMSutariyaVBReversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterizationEur J Pharm Biopharm200765221523216982178
  • ChenSCWuYCMiFLLinYHYuLCSungHWA novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug deliveryJ Control Release200496228530015081219
  • SartoriCFinchDSRalphBDetermination of the cation content of alginate thin films by FTIR spectroscopyPolymer19973814351
  • SocratesGInfrared and Raman Characteristic Group Frequencies: Tables and Charts3rd edChichesterJ Wiley & Sons2001
  • WanYLuXDalaiSZhangJThermophysical properties of polycaprolactone/chitosan blend membranesThermochim Acta20094871–23338
  • Fernández-HervásMJHolgadoMAFiniAFellJTIn vitro evaluation of alginate beads of a diclofenac saltInt J Pharm19981631–22334
  • LeeCWYenFLHuangHWResveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathwaysJ Agric Food Chem201260184662467122480310
  • TzengCWYenFLWuTHEnhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering processJ Agric Food Chem20115995073508021417334
  • NieHLeeLYTongHWangCHPLGA/chitosan composites from a combination of spray drying and supercritical fluid foaming techniques: new carriers for DNA deliveryJ Control Release2008129320721418539352
  • MakraduliLCrcarevskaMSGeskovskiNDodovMGGoracinovaKFactorial design analysis and optimisation of alginate-Ca-chitosan microspheresJ Microencapsul Epub July 3, 2012
  • DanhierFFeronOPréatVTo exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJ Control Release2010148213514620797419
  • LeeESOhKTKimDYounYSBaeYHTumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly-(ethylene glycol)- b-poly(L-histidine)J Control Release20071231192617826863
  • BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
  • TanJPWangQTamKCControl of burst release from nanogels via layer by layer assemblyJ Control Release2008128324825418457895
  • MehtaAKYadavKSSawantKKNimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluationCurr Drug Deliv20074318519317627492
  • KorsmeyerRWGurneyRDoelkerEBuriPPeppasNAMechanism of solute release from porous hydrophilic polymerJ Pharm Sci19831512535
  • OralloFComparative studies of the antioxidant effects of cis- and trans-resveratrolCurr Med Chem2006131879816457641
  • AbdelwahedWDegobertGStainmesseSFessiHFreeze-drying of nanoparticles: formulation, process and storage considerationsAdv Drug Deliv Rev200658151688171317118485
  • LemoineDFrancoisCKedzierewiczFPreatVHoffmanMMaincentPStability study of nanoparticles of poly(ɛ-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)Biomaterials19961722219121978922605